Psyomics Secures £2.4 Million for Mental Health Innovation
Psyomics, a groundbreaking healthtech company located in the historic city of Cambridge, UK, has recently secured an impressive £2.4 million in funding to further its mission of enhancing mental health assessments. This funding round, which saw participation from esteemed investors such as Parkwalk, Meltwind, and Newable Ventures, is aimed at expanding access to Psyomics' innovative online mental health assessment platform. By utilizing these funds, Psyomics plans to improve its services for individual users and various NHS trusts, thereby making mental health resources more accessible to those in need.
The company was co-founded by notable figures in the field: Professor Sabine Bahn, who serves as the head of the Cambridge Centre for Neuropsychiatric Research (CCNR), and Daniel Cowell, the former Chief Operating Officer of Horizon Discovery.
Together, they are focused on developing advanced technology designed to transform how mental health conditions are assessed and triaged. Their flagship digital diagnostic support platform, known as Censeo, effectively replicates the thoroughness of traditional face-to-face assessments in a convenient digital format. Users are guided through a thoughtfully constructed series of adaptive questions, which ultimately helps in painting a comprehensive portrait of their mental health symptoms and concerns.
Upon completion of the assessment, Censeo generates a detailed report that outlines potential conditions along with recommended next steps. This feature not only empowers patients in a stigma-free manner but also encourages them to engage proactively with their mental health. When utilized in a healthcare setting, the platform significantly aids clinicians—regardless of whether they are psychiatrists—by facilitating efficient decision-making processes. This ease of use is critical in helping healthcare providers establish the most appropriate care pathways and support levels swiftly. A pilot project within GP practices conducted last year yielded encouraging feedback from both general practitioners and patients alike. Following this success, Psyomics has opened access to Censeo for individual users, and exciting new collaborations with NHS treatment providers are on the horizon, promising to further innovate mental health care delivery.
They've invested in Psyomics
Get to know these Healthtech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Parkwalk( ) | ||||
 Meltwind( ) | ||||
 Newable Ventures( ) | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK